Recombinant Human Endothelial-Monocyte A Activating Polypeptide II (rHu EMAP-II)
Description
MW: 34,353 Da. Purity >98% by SDS-PAGE and HPLC analyses. EMAP-II is a tumor derived cytokine that exerts a wide range of activities on endothelial cells, monocytes and neutrophils. EMAP-II inhibits endothelial cell proliferation, vasculogenesis, neovessel formation, and can induce apoptosis. It is also chemotactic towards neutrophils and monocytes and induces myeloperoxidase activity from neutrophils. Of clinical importance, EMAP-II inhibits angiogenesis of vascular beds and suppresses the grow
Size
0.005 mg, 0.02 mg, 1 mg
Concentration
n/a
Applications
n/a
Other Names
[Endothelial-Monocyte Activating Polypeptide II; human EMAP-II; Human Endothelial-Monocyte Activating Polypeptide II]